A Deep Learning-Based Decision Support Tool for Precision Risk Assessment of Breast Cancer.

Journal: JCO clinical cancer informatics
Published Date:

Abstract

PURPOSE: The Breast Imaging Reporting and Data System (BI-RADS) lexicon was developed to standardize mammographic reporting to assess cancer risk and facilitate the decision to biopsy. Because of substantial interobserver variability in the application of the BI-RADS lexicon, the decision to biopsy varies greatly and results in overdiagnosis and excessive biopsies. The false-positive rate from mammograms is estimated to be 7% to approximately 10% overall, but within the BI-RADS 4 category, it is greater than 70%. Therefore, we developed the Breast Cancer Risk Calculator (BRISK) to target a well-characterized and specific patient subgroup (BI-RADS 4) rather than a broad heterogeneous group in assessing breast cancer risk.

Authors

  • Tiancheng He
    Houston Methodist, Houston, TX.
  • Mamta Puppala
    Houston Methodist, Houston, TX.
  • Chika F Ezeana
    Houston Methodist, Houston, TX.
  • Yan-Siang Huang
    Houston Methodist, Houston, TX.
  • Ping-Hsuan Chou
    Houston Methodist, Houston, TX.
  • Xiaohui Yu
    Beijing Key Laboratory for Green Catalysis and Separation, Key Laboratory of Beijing on Regional Air Pollution Control, Key Laboratory of Advanced Functional Materials, Education Ministry of China, Laboratory of Catalysis Chemistry and Nanoscience, Department of Environmental Chemical Engineering, School of Environmental and Chemical Engineering, Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China.
  • Shenyi Chen
    Houston Methodist, Houston, TX.
  • Lin Wang
    Department of Engineering Mechanics, Tsinghua University, Beijing 100084, China.
  • Zheng Yin
    Houston Methodist, Houston, TX.
  • Rebecca L Danforth
    Houston Methodist, Houston, TX.
  • Joe Ensor
    Houston Methodist, Houston, TX.
  • Jenny Chang
    Houston Methodist, Houston, TX.
  • Tejal Patel
    Houston Methodist, Houston, TX.
  • Stephen T C Wong
    Translational Biophotonics Laboratory, Department of Systems Medicine and Bioengineering, Houston Me, United States.